Cargando…
Atezolizumab plus bevacizumab for patients with Child-Pugh-B in hepatocellular carcinoma
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745609/ https://www.ncbi.nlm.nih.gov/pubmed/36523932 http://dx.doi.org/10.21037/hbsn-22-432 |
| _version_ | 1784849185335410688 |
|---|---|
| author | Itoh, Shinji Ikeda, Masafumi |
| author_facet | Itoh, Shinji Ikeda, Masafumi |
| author_sort | Itoh, Shinji |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9745609 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97456092022-12-14 Atezolizumab plus bevacizumab for patients with Child-Pugh-B in hepatocellular carcinoma Itoh, Shinji Ikeda, Masafumi Hepatobiliary Surg Nutr Editorial AME Publishing Company 2022-12 /pmc/articles/PMC9745609/ /pubmed/36523932 http://dx.doi.org/10.21037/hbsn-22-432 Text en 2022 Hepatobiliary Surgery and Nutrition. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Itoh, Shinji Ikeda, Masafumi Atezolizumab plus bevacizumab for patients with Child-Pugh-B in hepatocellular carcinoma |
| title | Atezolizumab plus bevacizumab for patients with Child-Pugh-B in hepatocellular carcinoma |
| title_full | Atezolizumab plus bevacizumab for patients with Child-Pugh-B in hepatocellular carcinoma |
| title_fullStr | Atezolizumab plus bevacizumab for patients with Child-Pugh-B in hepatocellular carcinoma |
| title_full_unstemmed | Atezolizumab plus bevacizumab for patients with Child-Pugh-B in hepatocellular carcinoma |
| title_short | Atezolizumab plus bevacizumab for patients with Child-Pugh-B in hepatocellular carcinoma |
| title_sort | atezolizumab plus bevacizumab for patients with child-pugh-b in hepatocellular carcinoma |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745609/ https://www.ncbi.nlm.nih.gov/pubmed/36523932 http://dx.doi.org/10.21037/hbsn-22-432 |
| work_keys_str_mv | AT itohshinji atezolizumabplusbevacizumabforpatientswithchildpughbinhepatocellularcarcinoma AT ikedamasafumi atezolizumabplusbevacizumabforpatientswithchildpughbinhepatocellularcarcinoma |